🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether mixed H. pylori strain in...
Status
Completed
Location
Institute of microbiology and immunology
Start Date
2008-11
Trial ID
NCT01164969
Treatments Being Tested
Epidermolysis Bullosa(EB) is an inherited bullous disease. Tetracycline is ...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00336154
Treatments Being Tested
RATIONALE: Antibiotics may stop the growth of Helicobacter pylori which may...
Status
Completed
Location
Royal United Hospital
Start Date
1997-09
Trial ID
NCT00003151
The aim of this study is to Identify antibiotic resistance gene mutations i...
Status
Unknown
Location
Seoul National University Boramae Medical Center
Start Date
2019-05-01
Trial ID
NCT03837990
Treatments Being Tested
This study aims to evaluate the pharmacokinetic interaction between tegopra...
Status
Completed
Location
Chonbuk National University Hospital
Start Date
2019-01-17
Trial ID
NCT04066257
Treatments Being Tested
Ameloblastoma is an epithelial odontogenic tumor. Although ameloblastoma is...
Status
Completed
Location
Faculty of Dentistry, Minia University
Start Date
2024-02-10
Trial ID
NCT06759610
Treatments Being Tested
The aim of this study was to investigate the effect of an oxytetracycline i...
Status
Completed
Location
Tore Bjornland
Start Date
2016-01-02
Trial ID
NCT03494972
Treatments Being Tested
Based on the current literature, investigators hypothesize that patients wi...
Status
Terminated
Location
University of Louisville
Start Date
2014-03-06
Trial ID
NCT02099240
Treatments Being Tested
Aim: The aim of this prospective, randomized, parallel arm, blind clinical...
Status
Completed
Location
Aristotle University of Thessaloniki
Start Date
2024-02-05
Trial ID
NCT06695559
Treatments Being Tested